Back
Speaker illustration

Associate Professor Michel Zeitouni

Pitie Salpetriere APHP University Hospital, Paris (France)

Member of:

European Society of Cardiology

Presentations

Heart rate and cardiovascular outcomes with and without beta-blocker in post-mi patients: a pre-specified analysis of the ABYSS trial.

Event: ESC Congress 2025

Topic: Chronic Ischaemia

Session: Novel pharmacological approaches in acute coronary syndromes

Access
Like
Thumbnail

Hydroceramide as a novel Biomarker of Premature Atherosclerosis

Event: ESC Congress 2025

Topic: Biomarkers

Session: Biomarkers in acute coronary syndromes (4)

Access
Like
Thumbnail

Intra venous antithrombotic in acute myocardial infarction complicated with cardiogenic shock

Event: ESC Congress 2025

Topic: Antiplatelet Drugs

Session: Antithrombotic pharmacotherapy

Access
Like
Thumbnail

Pre-treatment with P2Y12 inhibitors in acute myocardial infarction with cardiogenic shock

Event: ESC Congress 2025

Topic: Antiplatelet Drugs

Session: Antithrombotic pharmacotherapy

Access
Like
Thumbnail

Levosimendan in patients with cardiogenic shock refractory to dobutamine weaning

Event: ESC Congress 2024

Topic: Cardiogenic Shock

Session: New insights into pharmacotherapy for acute heart failure

Access
Like
Thumbnail

Early versus delayed introduction of renin angiotensin aldosterone system inhibitors in cardiogenic shock

Event: ESC Congress 2023

Topic: Pharmacotherapy

Session: Acute heart failure: prevention and treatment

Access
Like
Thumbnail

Have the ESC guidelines improved the identification and prevention of individuals at risk of premature myocardial infarction?

Event: ESC Congress 2022

Topic: Scores

Session: Cardiovascular risk assessment - Scores 1

Access
Like
Thumbnail

Causes and predictors of short, intermediate and long-term mortality in patients after PCI

Event: ESC Congress 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Long term prognosis in coronary artery disease

Access
Like
Thumbnail

Apixaban 2.5 mg twice daily is effective and safe for patients with atrial fibrillation and combinations of advanced age, low body weight, and elevated creatinine: insights from ARISTOTLE

Event: ESC Congress 2019

Topic: Oral Anticoagulation

Session: Atrial fibrillation and oral anticoagulation 1

Access
Like
Thumbnail

Investigator versus Core Lab evaluation of coronary blood flow in PCI of patients in cardiogenic shock: a substudy of the CULPRIT-SHOCK trial.

Event: ESC Congress 2019

Topic: Coronary Angiography

Session: High risk percutaneous coronary intervention: STEMI, CTO, atherectomy bifurcations shock

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources